Peptidomimetic agents from dextrorotatory amino acids as...

Details Peptidomimetic agents from dextrorotatory amino acids as... Peptidomimetic agents from dextrorotatory amino acids as...

2011-03-29

2011-03-29

Kolker, Daniel E (Department: 1649)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S017800, C514S021700, C514S021800, C530S329000

Reexamination Certificate

active

07915220

ABSTRACT:
A peptidomimetic agent from dextrorotatory amino acids includes vGek with Dval-gly-Dglu-Dlys as a central D-amino acid sequence, whereby gly is equal to D-glycine, which is equal to L-glycine. Pharmaceutical agents for use in the treatment of neurodegenerative diseases, in particular Alzheimer's disease, Parkinson's disease, Lewy Body dementia, Creutzfeldt-Jakob disease, as well as Huntington's Chorea disease, multi-system atrophy as well as disorders similar to these neurodegenerative diseases that contain at least one peptidomimetic agent from dextrorotatory amino acids are also included.

REFERENCES:
patent: 2005/0287565 (2005-12-01), Merchiers et al.
patent: 2006/0036073 (2006-02-01), Windisch
patent: 2009/0286745 (2009-11-01), Zurdo et al.
patent: 03/082906 (2003-10-01), None
patent: WO 2005/023858 (2005-03-01), None
Fischer 2003 (Current Protein and Peptide Science 4:339-356).
Taylor et al. 2000 Journal of Pharmacology and Experimental Therapeutics 295:190-194.

Affiliated with

Also associated with

Rating

Peptidomimetic agents from dextrorotatory amino acids as... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptidomimetic agents from dextrorotatory amino acids as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptidomimetic agents from dextrorotatory amino acids as... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2658803